STOCK TITAN

Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

SAN FRANCISCO, July 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2023 financial results on Tuesday, August 8, 2023, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

To access the conference call, please register at the link below:
https://www.netroadshow.com/events/login?show=53f2c7d8&confId=53596

Upon registering, each participant will be provided with call details and access codes. 

The live webcast of the call and slide deck may be accessed here or by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website.

About Invitae
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

To learn more, visit invitae.com and follow for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.

Invitae Contacts:

Investor Relations
Hoki Luk
ir@invitae.com

Public Relations
Amy Hadsock
pr@invitae.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-announce-second-quarter-2023-financial-results-on-tuesday-august-8-2023-301886511.html

SOURCE Invitae Corporation

Invitae Corporation

NYSE:NVTA

NVTA Rankings

NVTA Latest News

NVTA Stock Data

5.59M
284.38M
1.51%
47.96%
23.65%
Diagnostics & Research
Healthcare
Link
United States
San Francisco